To Investigate the Effect of Intravenous Ondansetron on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 16, 2011

Primary Completion Date

December 19, 2011

Study Completion Date

December 19, 2011

Conditions
Nausea and Vomiting, Chemotherapy-Induced
Interventions
DRUG

ondansetron

FDA approved drug used to treat nausea and vomiting

DRUG

moxifloxacin

FDA approved antibiotic commonly used as a positive control in thorough QT studies

OTHER

saline

USP saline IV solution used as placebo for ondansetron IV.

Trial Locations (1)

78744

GSK Investigational Site, Austin

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01449188 - To Investigate the Effect of Intravenous Ondansetron on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter